We found that down-regulation of NR5A2 was associated with significantly shorter DFS in the HNSCC patients with wild-type TP53 but not in those in TP53 mutation (Supplementary Figures 2E, F). The gene discussed is NR5A2; the disease is head and neck squamous cell carcinoma.